Tuberculosis News and Research

Latest Tuberculosis News and Research

Deep learning could transform the ability to accurately interpret HIV test results

Pioneering technology developed by UCL and Africa Health Research Institute researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries.

18 Jun 2021

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Scientists have a general idea of how viruses invade and spread in the body, but the precise mechanisms are actually not well understood, especially when it comes to Ebola virus.

18 Jun 2021

Study validates accuracy of new molecular test for tuberculosis diagnosis

The 'Xpert Ultra' molecular test has a greater capacity than its predecessor ('Xpert MTB/RIF') in detecting tuberculosis cases, either passively (i.e. people who attend the hospital with disease symptoms) or actively (searching for possible cases in the community among contacts of cases).

17 Jun 2021

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice.

16 Jun 2021

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

The researchers found that individuals with registered diphtheria or tetanus vaccinations were less likely to develop severe COVID-19 than people who had only received other vaccinations. The results of this study are posted to the medRxiv* preprint server.

16 Jun 2021

Studies shed new light on disease processes in tuberculosis

Two new studies have cast unprecedented light on disease processes in tuberculosis, identifying key genetic changes that cause damage in the lungs and a drug treatment that could speed up recovery.

16 Jun 2021

New web tool offers many capabilities vital to bacteria mutation research

In 1943, two scientists named Max Delbrück and Salvador Luria conducted an experiment to show that bacteria can mutate randomly, independent of external stimulus, such as an antibiotic that threatens a bacterial cells' survival.

15 Jun 2021

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The AIDS Clinical Trials Group, the largest global HIV research network, today announced the launch of A5386, a phase 1 HIV cure study evaluating two promising therapies.

10 Jun 2021

Study explores the immune response to COVID-19-specific vaccines in Brazilian healthcare workers

An Australian-led study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.

9 Jun 2021

Shorter treatment regimen found to be effective for treating TB

Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.

5 Jun 2021

Study reveals infections by Histoplasma fungus as major cause of death in people with HIV

A series of autopsies performed in an infectious disease hospital in the Brazilian Amazon reveals that infections by the Histoplasma fungus are a major cause of death in people with HIV.

1 Jun 2021

Study supports the need for improving early TB diagnosis and care in Irish prisons

Investigators from Trinity College Dublin, the Irish Mycobacteria Reference Laboratory, St James's Hospital, and the Department of Public Health HSE East believe tuberculosis (TB) care in Irish Prisons should be supported, considering the findings of their study which is published today (Tuesday, 1st June, 2021) in the International Journal of Tuberculosis and Lung Disease.

1 Jun 2021

Reusing old vaccines to boost innate immunity against COVID-19

The COVID-19 vaccine is currently the best form of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. But a new perspective article published in the journal PNAS suggests it’s not the panacea to stopping SARS-CoV-2.

31 May 2021

FIRS calls on governments and policymakers to support and promote tobacco cessation services

On World No Tobacco Day (31 May, 2021) the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians® (CHEST) is a founding member, calls on governments and policymakers to make greater political and financial commitments to support and promote tobacco cessation services.

29 May 2021

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

In a study published in the Royal Society Open Science journal, researchers simulated many aircraft boarding processes to assess their impact on social proximity during boarding. They also studied the dominant mechanisms by which these processes generate social proximity. The researchers systematically measured proximity by measuring the number of contacts originating from the following situations: 1. contacts between seated passenger pairs; 2. contacts between aisle passenger pairs; and 3. contacts between a seated passenger and an aisle passenger.

26 May 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

Deep learning could transform the ability to accurately interpret HIV test results

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Study validates accuracy of new molecular test for tuberculosis diagnosis

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

Prior vaccination against diphtheria and tetanus associated with less severe COVID-19

Studies shed new light on disease processes in tuberculosis

New web tool offers many capabilities vital to bacteria mutation research

ACTG launches phase 1 HIV cure study evaluating two promising therapies

Study explores the immune response to COVID-19-specific vaccines in Brazilian healthcare workers

Shorter treatment regimen found to be effective for treating TB

Study reveals infections by Histoplasma fungus as major cause of death in people with HIV

Study supports the need for improving early TB diagnosis and care in Irish prisons

Reusing old vaccines to boost innate immunity against COVID-19

FIRS calls on governments and policymakers to support and promote tobacco cessation services

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

Zoonotic and vector-borne emerging tropical diseases pose a constant threat

Scientists propose new strategies to find drugs that neutralize critical enzymes

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

Despite pandemic, Newsom declines to boost local public health budgets — again

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Forensics and toxicology - Industry Focus eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Tuberculosis News and Research

Latest Tuberculosis News and Research

Forensics and toxicology - Industry Focus eBook eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in